|
|
| | 11-Hydroxytetrahydrocannabinol Basic information |
| Product Name: | 11-Hydroxytetrahydrocannabinol | | Synonyms: | (±)-11-Hydroxy-Δ9-THC solution;(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol;(-11-hydroxy-9-THC (CRM);raceMic Dronabinol Metabolite: (±)-11-Hydroxy-Δ9-tetrahydrocannabinol;(±)-trans-11-OH-Δ9-THC;6H-Dibenzo[b,d]pyran-9-methanol, 6a,7,8,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-, (6aR,10aR)-rel-;(±)-11-hydroxy-Δ9-THC;(±)-11-hydroxy-Δ9-THC (CRM) | | CAS: | 34675-49-5 | | MF: | C21H30O3 | | MW: | 330.46 | | EINECS: | 803-555-4 | | Product Categories: | Metabolite | | Mol File: | 34675-49-5.mol |  |
| | 11-Hydroxytetrahydrocannabinol Chemical Properties |
| Boiling point | 437.1±45.0 °C(Predicted) | | density | 1.071±0.06 g/cm3(Predicted) | | Fp | 9℃ | | storage temp. | 2-8°C | | pka | 9.78±0.60(Predicted) | | form | liquid | | Major Application | cannabis testing
forensics and toxicology | | InChI | 1S/C21H30O3/c1-4-5-6-7-14-11-18(23)20-16-10-15(13-22)8-9-17(16)21(2,3)24-19(20)12-14/h10-12,16-17,22-23H,4-9,13H2,1-3H3 | | InChIKey | YCBKSSAWEUDACY-UHFFFAOYSA-N | | SMILES | OC1=CC(CCCCC)=CC2=C1C3C=C(CO)CCC3C(O2)(C)C |
| Hazard Codes | F,T | | Risk Statements | 11-23/24/25-39/23/24/25 | | Safety Statements | 7-16-36/37-45 | | RIDADR | UN1230 - class 3 - PG 2 - Methanol, solution | | WGK Germany | 1 | | Storage Class | 3 - Flammable liquids | | Hazard Classifications | Acute Tox. 3 Dermal
Acute Tox. 3 Inhalation
Acute Tox. 3 Oral
Flam. Liq. 2
STOT SE 1 |
| | 11-Hydroxytetrahydrocannabinol Usage And Synthesis |
| Uses | The Certified Spiking Solution(R) is suitable for (±)-11-Hydroxy-Δ9-THC testing by HPLC, GC/MS, or LC-MS/MS methods in forensic analysis, clinical toxicology, urine drug testing, and Cannabis potency or impurity profiling testing applications. The Certified Reference Material (CRM) in solution can also be used as follows:- Quantification of cannabidiol and Δ9-tetrahydrocannabinol in addition to the identification of minor cannabinoids from human plasma samples using ultra-performance liquid chromatography (UHPLC) combined with triple quadrupole mass spectrometry following a liquid-liquid extraction
- Liquid chromatography-tandem mass spectrometry (LC-MS/MS) method-based determination of 10 cannabinoids in oral fluid samples following their solid phase extraction (SPE)
- Analysis of Δ9-Tetrahydrocannabinol (Δ9-THC) and its three metabolites in plasma and urine samples by gas chromatography (GC) coupled to triple quadrupole mass spectrometer
- Development of an automated sample preparation method based on solid phase extraction (SPE) to determine ∆9-tetrahydrocannabinol (THC) and its three primary metabolites in a variety of matrices, such as serum, saliva, and urine using liquid chromatography-mass spectrometry (LC-MS)
- Simultaneous determination of cannabinoids and their metabolites in human serum samples by an atmospheric-pressure chemical ionization gas chromatography-tandem mass spectrometry (APGC-MS/MS)
| | Definition | ChEBI: 11-hydroxy-Delta(9)-tetrahydrocannabinol is a phytocannabinoid that is Delta(9)-tetrahydrocannabinol in which the methyl group at C-11 has been hydroxylated. Major metabolite of Delta(9)-tetrahydrocannabinol. It has a role as a human xenobiotic metabolite. It is functionally related to a Delta(9)-tetrahydrocannabinol. |
| | 11-Hydroxytetrahydrocannabinol Preparation Products And Raw materials |
|